Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
Medulloblastoma (MB), a primary tumor of the central nervous system, is among the most prevalent pediatric neoplasms. The median age of diagnosis is six. Conventional therapies include surgical resection of the tumor with subsequent radiation and chemotherapy. However, these therapies often cause se...
Enregistré dans:
Auteurs principaux: | Marije J. Voskamp, Shuang Li, Kim R. van Daalen, Sandra Crnko, Toine ten Broeke, Niels Bovenschen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f9ba5ad4231f4e77a01d0a50ea3e9f7d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
par: Xin Cai, et autres
Publié: (2021) -
The impact of magnetic resonance imaging spectroscopy parameters on differentiating between paediatric medulloblastoma and ependymoma
par: Nguyen Minh Duc
Publié: (2021) -
Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
par: Jagmohan Singh, et autres
Publié: (2021) -
Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China
par: Anwen Xiong, et autres
Publié: (2021) -
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
par: Shijie Shang, et autres
Publié: (2021)